Hims & Hers: A Bold Buyback Amid Market Skepticism

The telehealth sector’s rising star, Hims & Hers, has made a dramatic move to demonstrate faith in its own valuation, authorizing a massive $250 million share repurchase initiative. This substantial capital return program arrives during a period of significant stock price weakness, creating a stark contrast between corporate confidence and market sentiment. Investors are left questioning whether this represents a strategic masterstroke or misguided corporate activism.

Operational metrics tell a compelling growth story that appears disconnected from the company’s market valuation. For the third quarter of 2025, Hims & Hers reported revenue reaching $599 million, representing a robust 49 percent year-over-year increase. The company continues to demonstrate improving profitability while expanding Read more...